Sign Up to like & get
recommendations!
0
Published in 2025 at "Medical Physics"
DOI: 10.1002/mp.70030
Abstract: Personalized pretreatment dosimetry planning is crucial for optimizing [177Lu]Lu–prostate‐specific membrane antigen‐617 (Lu‐PSMA) radioligand therapy (RLT) in patients with metastatic castration‐resistant prostate cancer (mCRPC).
read more here.
Keywords:
psma 617;
617 treatment;
transforming 177lu;
psma ... See more keywords